Public health interventions to control the current epidemic of carbapenem-resistant Klebsiella pneumoniae rely on a comprehensive understanding of its emergence and spread over a wide range of geographical scales. We analysed the genome sequences and epidemiological data of >1,700 K. pneumoniae samples isolated from patients in 244 hospitals in 32 countries during the European Survey of Carbapenemase-Producing Enterobacteriaceae. We demonstrate that carbapenemase acquisition is the main cause of carbapenem resistance and that it occurred across diverse phylogenetic backgrounds. However, 477 of 682 (69.9%) carbapenemase-positive isolates are concentrated in four clonal lineages, sequence types 11, 15, 101, 258/512 and their derivatives. Combined analysis of the genetic and geographic distances between isolates with different β-lactam resistance determinants suggests that the propensity of K. pneumoniae to spread in hospital environments correlates with the degree of resistance and that carbapenemase-positive isolates have the highest transmissibility. Indeed, we found that over half of the hospitals that contributed carbapenemase-positive isolates probably experienced within-hospital transmission, and interhospital spread is far more frequent within, rather than between, countries. Finally, we propose a value of 21 for the number of single nucleotide polymorphisms that optimizes the discrimination of hospital clusters and detail the international spread of the successful epidemic lineage, ST258/512.

Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread / David S.; Reuter S.; Harris S.R.; Glasner C.; Feltwell T.; Argimon S.; Abudahab K.; Goater R.; Giani T.; Errico G.; Aspbury M.; Sjunnebo S.; Koraqi A.; Lacej D.; Apfalter P.; Hartl R.; Glupczynski Y.; Huang T.-D.; Strateva T.; Marteva-Proevska Y.; Andrasevic A.T.; Butic I.; Pieridou-Bagatzouni D.; Maikanti-Charalampous P.; Hrabak J.; Zemlickova H.; Hammerum A.; Jakobsen L.; Ivanova M.; Pavelkovich A.; Jalava J.; Osterblad M.; Dortet L.; Vaux S.; Kaase M.; Gatermann S.G.; Vatopoulos A.; Tryfinopoulou K.; Toth A.; Janvari L.; Boo T.W.; McGrath E.; Carmeli Y.; Adler A.; Pantosti A.; Monaco M.; Raka L.; Kurti A.; Balode A.; Saule M.; Miciuleviciene J.; Mierauskaite A.; Perrin-Weniger M.; Reichert P.; Nestorova N.; Debattista S.; Mijovic G.; Lopicic M.; Samuelsen O.; Haldorsen B.; Zabicka D.; Literacka E.; Canica M.; Manageiro V.; Kaftandzieva A.; Trajkovska-Dokic E.; Damian M.; Lixandru B.; Jelesic Z.; Trudic A.; Niks M.; Schreterova E.; Pirs M.; Cerar T.; Oteo J.; Aracil B.; Giske C.; Sjostrom K.; Gur D.; Cakar A.; Woodford N.; Hopkins K.; Wiuff C.; Brown D.J.; Feil E.J.; Rossolini G.M.; Aanensen D.M.; Grundmann H.. - In: NATURE MICROBIOLOGY. - ISSN 2058-5276. - ELETTRONICO. - 4:(2019), pp. 1919-1929. [10.1038/s41564-019-0492-8]

Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread

Giani T.;Rossolini G. M.;
2019

Abstract

Public health interventions to control the current epidemic of carbapenem-resistant Klebsiella pneumoniae rely on a comprehensive understanding of its emergence and spread over a wide range of geographical scales. We analysed the genome sequences and epidemiological data of >1,700 K. pneumoniae samples isolated from patients in 244 hospitals in 32 countries during the European Survey of Carbapenemase-Producing Enterobacteriaceae. We demonstrate that carbapenemase acquisition is the main cause of carbapenem resistance and that it occurred across diverse phylogenetic backgrounds. However, 477 of 682 (69.9%) carbapenemase-positive isolates are concentrated in four clonal lineages, sequence types 11, 15, 101, 258/512 and their derivatives. Combined analysis of the genetic and geographic distances between isolates with different β-lactam resistance determinants suggests that the propensity of K. pneumoniae to spread in hospital environments correlates with the degree of resistance and that carbapenemase-positive isolates have the highest transmissibility. Indeed, we found that over half of the hospitals that contributed carbapenemase-positive isolates probably experienced within-hospital transmission, and interhospital spread is far more frequent within, rather than between, countries. Finally, we propose a value of 21 for the number of single nucleotide polymorphisms that optimizes the discrimination of hospital clusters and detail the international spread of the successful epidemic lineage, ST258/512.
2019
4
1919
1929
David S.; Reuter S.; Harris S.R.; Glasner C.; Feltwell T.; Argimon S.; Abudahab K.; Goater R.; Giani T.; Errico G.; Aspbury M.; Sjunnebo S.; Koraqi A....espandi
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1218624
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 422
  • ???jsp.display-item.citation.isi??? 343
social impact